Literature DB >> 8474699

Limited but evident protective effects of MK-801 and pentobarbital on neuronal damage following forebrain ischemia in the gerbil under normothermic conditions.

K Murase1, H Kato, K Kogure.   

Abstract

The purpose of this study was to examine the protective effects of an N-methyl-D-aspartate receptor antagonist, MK-801, and pentobarbital against neuronal damage in a global ischemia model under controlled body temperature. Gerbils were subjected to 3 and 5 min of bilateral common carotid artery occlusion. MK-801 (1 and 5 mg/kg, i.p.), administered 30 min before ischemia, significantly attenuated the degeneration of hippocampal CA1 pyramidal cells after 3 min of ischemia in a dose dependent manner, but had no such effects after 5 min of ischemia. Pentobarbital (40 mg/kg, i.p.) also protected against CA1 damage after 3 min of ischemia but not after 5 min of ischemia. Thus, we confirmed the protective effects of these agents under normothermic conditions, although these effects were limited to shorter periods of ischemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8474699     DOI: 10.1016/0304-3940(93)90778-j

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

Review 1.  Calcium, energy metabolism and the development of selective neuronal loss following short-term cerebral ischemia.

Authors:  N R Sims
Journal:  Metab Brain Dis       Date:  1995-09       Impact factor: 3.584

2.  Multiple cyclin-dependent kinases signals are critical mediators of ischemia/hypoxic neuronal death in vitro and in vivo.

Authors:  Juliet Rashidian; Grace Iyirhiaro; Hossein Aleyasin; Mario Rios; Inez Vincent; Steven Callaghan; Ross J Bland; Ruth S Slack; Matthew J During; David S Park
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-15       Impact factor: 11.205

3.  Protein synthesis in the hippocampal slice: transient inhibition by glutamate and lasting inhibition by ischemia.

Authors:  B Djuricic; G Röhn; W Paschen; K A Hossmann
Journal:  Metab Brain Dis       Date:  1994-09       Impact factor: 3.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.